Riskpilot← Back to searchSign inGet full accessGENOMAR GENETICS AS
ASActiveOrg 915894658Bolette Brygge 1, 0252 OsloResearch and experimental development on natural sciences and engineering · NACE 7210Est. 20154 employees
Revenue 2025
NOK 9,2M
+17% vs 2024
EBITDA margin
-240.6%
+24% vs 2024
Equity ratio
52.6%
Financial strength
Net profit 2025
NOK -10,9M
+64% vs 2024
| Revenue | NOK 9,2M | +17% |
| EBITDA | NOK -22,2M | +24% |
| Net profit | NOK -10,9M | +64% |
| Total assets | NOK 286,7M | +25% |
| Equity | NOK 150,8M | +27% |
| Employees | 4 | — |
Legal name
GENOMAR GENETICS AS
Org number
915894658
Legal form
Aksjeselskap
NACE code
7210 · Research and experimental development on natural sciences and engineering
Founded
9. september 2015
Share capital
NOK 239 500 000
Employees
4 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Styrets leder alene.
Company purpose
Kommersialisering av og handel med bioteknologisk kunnskap og genetikk samt alt som hermed står i forbindelse innenfor området oppdretts- og aquakulturnæringen, herunder investere i selskaper og prosjekter som direkte eller indirekte driver lignende virksomhet.
Address
Bolette Brygge 1, 0252 Oslo
Phone
+4748328271
Email
genomar@genomar.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Revenue | 201 | 0 | 0 | 2 141 | 6 535 | 6 786 | 6 998 | 7 883 | 9 210 |
| Staff expenses | −537 | −2 928 | −3 283 | −3 697 | −5 293 | −5 568 | −6 108 | −6 618 | −5 173 |
| EBITDA | −869 | −13 875 | −11 256 | −14 398 | −17 675 | −21 656 | −29 230 | −29 335 | −22 159 |
| Depreciation & amort. | −178 | −2 755 | −1 381 | −1 280 | −27 | −26 | −0 | −0 | −0 |
| EBIT | −1 047 | −16 630 | −12 637 | −15 678 | −17 702 | −21 682 | −29 230 | −29 335 | −22 159 |
| Net financials | −1 336 | −3 999 | 1 635 | 2 662 | −4 744 | 16 482 | 23 122 | −7 924 | 6 057 |
| Profit before tax | −2 383 | −20 630 | −11 002 | −13 015 | −22 445 | −5 200 | −6 107 | −37 259 | −16 101 |
| Tax | −0 | −6 510 | −2 572 | −3 157 | −5 199 | −1 462 | −1 534 | −6 823 | −5 186 |
| Net profit | −2 383 | −14 119 | −8 430 | −9 858 | −17 246 | −3 738 | −4 573 | −30 436 | −10 915 |
| Item | 2016 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| Total assets | 41 349 | 59 509 | 70 990 | 112 422 | 146 340 | 162 791 | 204 007 | 228 908 | 286 720 |
| Equity | 14 846 | 12 010 | 9 973 | 10 535 | 3 656 | 143 332 | 143 989 | 119 046 | 150 790 |
| Long-term debt | 26 503 | 47 150 | 58 787 | 90 385 | 6 815 | 13 797 | 55 042 | 106 854 | 132 524 |
| Short-term debt | 0 | 349 | 2 229 | 11 503 | 135 869 | 5 662 | 4 975 | 3 008 | 3 406 |
| Total debt | 26 503 | 47 499 | 61 017 | 101 888 | 142 684 | 19 459 | 60 017 | 109 862 | 135 931 |
EBITDA margin
-240.6%
This company
15.8%
Market median
-1623% vs market
20162025
Equity ratio
52.6%
This company
38.2%
Market median
+38% vs market
20162025
Return on equity
-7.2%
This company
18.4%
Market median
-139% vs market
20162025
Net profit margin
-118.5%
This company
8.1%
Market median
-1563% vs market
20162025
Asset turnover
0.03×
This company
1.12×
Market median
-97% vs market
20162025
Debt / equity
0.90×
This company
0.62×
Market median
+45% vs market
20162025
- Annual report 2025Filed via Brønnøysundsregistrene · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2020-07-01 – 2021-06-30
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2019-07-01 – 2020-06-30
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2018-07-01 – 2019-06-30
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2017-01-01 – 2018-06-30
- Annual report 2016Filed via Brønnøysundsregistrene · Period 2015-08-31 – 2016-12-31
No data on file.
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2017 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Blue Future Holding As | Company | 100.0% | 100.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Blue Future Holding As
GENOMAR GENETICS AS Board members of GENOMAR GENETICS AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Odd Magne Rødseth | Chairman | 0 companies |